Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

INM InMed Pharmaceuticals Inc. Common Shares
$0.88 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy INM stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 2.5M
Enterprise value -4214867
Trailing PE 0.013715278
Forward PE -0.12336001
PEG Ratio -0.00015950035757188
Enterprise to EBITDA 0.552
Enterprise to revenue -0.935
Price to book MRQ 0.22550455
Price to sales TTM 0.49942163

Financials

Fiscal Year Ends 2025-06-30
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 4.5M
EBITDA -7630413
Diluted EPS TTM -2.88
Total Cash (MRQ) 7.0M
Current ratio (MRQ) 5.938
Operating Cash Flow (TTM) -7421862

INM trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent INM News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.